Table 2.
No. of reference | No. of patients | Mean age (years) | No. of tumor | Location of tumor | Treatment modality | Median tumor volume (mL) | Dose (Gy)/fraction | Median OS (months) | Local control rate (%) |
---|---|---|---|---|---|---|---|---|---|
6 | 51 | 55 | 72 | Stem, elquant area | Primary | 13.0 | 30–35/5 | 11 | 76 (at 1 year) |
9 | 37 | 60 | 38 | All | Primary | 17.6 | 30–41/3–5 | 10 | 87 (at 1 year) |
19 | 135 | 61 | 171 | All | Primary | 16.4 | 27–36/3 | 11 | 88 (at 1 year) |
22 | 21 | 59 | 27 | All | Primary | 5.4 | 20–40/5 | 10 | 86.7 (at 1 year) |
26 | 37 | <65 (73%) | 37 | All | Resection cavity | 28.8 | 24/3 | 6 | 80 (at 6 months) |
Present study | 23 | 61 | 29 | All | Primary or resection cavity | 18.0 | 24–33/2–3 | 10 | 91.7 (at 1 year) |
FSRS : fractionated stereotactic radiosurgery, OS : overall survival